Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.

Dermatology (Basel, Switzerland) - 1 Jan 2009

Cribier Bernard, Chiaverini Christine, Dali-Youcef Nassim, Schmitt Michèle, Grima Michèle, Hirth Christine, Lacour Jean-Philippe, Chosidow Olivier

Abstract excerpt

BACKGROUND: Hemochromatosis gene (HFE) mutations and the hepatitis C virus (HCV) are known risk factors for porphyria cutanea tarda (PCT), but interactions with erythrocytic uroporphyrinogen decarboxylase (UROD) have seldom been addressed. OBJECTIVE: In order to examine the links between these factors, we conducted a multicentre prospective case-control study. METHODS: PCT patients with (n = 32) or without HCV (n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Hemochromatosis Protein

Share to Hepatitis C

Share to Histocompatibility Antigens Class I

Share to Membrane Proteins

Share to Porphyria Cutanea Tarda

Source

Identifiers

PMID: 19001803
DOI: 10.1159/000173696

Genes

HFE
UROD

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.PMID 19001803Read ↗

Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.Semantic proximity Read ↗

[Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].Semantic proximity Read ↗

Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.Semantic proximity Read ↗

High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.Semantic proximity Read ↗

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.Semantic proximity Read ↗

Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.Semantic proximity Read ↗

Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.Semantic proximity Read ↗

High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.Semantic proximity Read ↗

Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).Semantic proximity Read ↗

C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.Semantic proximity Read ↗

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.Semantic proximity Read ↗

Iron overload in porphyria cutanea tarda.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.